Leqembi, first Alzheimer’s drug to slow disease, gets full FDA approval

Leqembi, first Alzheimer’s drug to slow disease, gets full FDA approval  CBS NewsFDA grants first ever approval for Alzheimer’s drug meant to slow disease  NBC NewsFDA Makes Alzheimer’s Drug Leqembi Widely Accessible  The New York TimesBiogen’s stock slides premarket as analysts take mixed view of Alzheimer’s disease drug approval  MarketWatchA new drug can delay Alzheimer’s progression | The Latest from WDEL News | wdel.com  1150AM/101.7FM WDELView Full Coverage on Google News…
Read More